GLP-1 medications such as Ozempic are dramatically changing people’s relationships with the foods they eat. Patients are finding they are eating less and craving less snack foods — and that’s changing their shopping habits.
This has left the food and beverage industry strategizing new ways to market to the Ozempic crowd. Nestlé is planning a GLP-1-friendly frozen-food line. Meanwhile, Danone and Coca-Cola are marketing high-protein, low-sugar products, also meant to appeal to GLP-1 users.
But are protein-infused packaged products really healthy for GLP-1 patients? On Cincinnati Edition, we discuss how the Ozempic craze has changed consumer habits and how the industry is responding.
Guests:
- Martha Belury, Ph.D., professor and chair, Ohio State University Department of Food Science and Technology
- Susan McElroy, MD, professor, University of Cincinnati College of Medicine Department of Psychiatry & Behavioral Neuroscience
- Jennifer Wittwer, MD, endocrinologist, The Christ Hospital Health Network
Ways to listen to this show:
- Tune in live at noon ET M-F. Call 513-419-7100 or email talk@wvxu.org to have your voice heard on today’s topic.
- Catch the replay on 91.7 WVXU and 88.5 WMUB at 8 p.m. ET M-F.
- Listen on-demand. Audio for this segment will be uploaded to this page by 4 p.m. ET., or subscribe to our podcast.